Pictet Asset Management
TMO icon

Pictet Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Pictet Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01B Sell
2,061,343
-400,813
-16% -$218M 1.07% 9
2025
Q4 		$1.43B Sell
2,462,156
-428,284
-15% -$242M 1.38% 8
2025
Q3 		$1.4B Buy
2,890,440
+42,003
+1% +$19.6M 1.35% 8
2025
Q2 		$1.16B Sell
2,848,437
-30,837
-1% -$12.9M 1.18% 12
2025
Q1 		$1.43B Buy
2,879,274
+193,378
+7% +$105M 1.59% 5
2024
Q4 		$1.4B Buy
2,685,896
+196,242
+8% +$108M 1.51% 6
2024
Q3 		$1.54B Buy
2,489,654
+1,995
+0.1% +$1.18M 1.69% 5
2024
Q2 		$1.38B Sell
2,487,659
-72,667
-3% -$41.6M 1.58% 6
2024
Q1 		$1.49B Sell
2,560,326
-64,410
-2% -$36.1M 1.62% 3
2023
Q4 		$1.39B Buy
2,624,736
+104,448
+4% +$50.6M 1.54% 5
2023
Q3 		$1.28B Buy
+2,520,288
New +$1.34B 1.57% 4

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pictet Asset Management's TMO Position: Q1 2026 in Review

Pictet Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q1 2026, selling an estimated $218M and leaving 2,061,343 shares worth $1.01B. The position accounts for 1.07% of the portfolio, ranked #9.

Pictet Asset Management first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.54B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Pictet Asset Management held 2,061,343 shares of Thermo Fisher Scientific worth $1.01B as of Q1 2026.
  • Pictet Asset Management sold 400,813 Thermo Fisher Scientific shares in Q1 2026, an estimated $218M.
  • Thermo Fisher Scientific made up 1.07% of Pictet Asset Management's portfolio in Q1 2026, its #9 holding.
  • Pictet Asset Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Thermo Fisher Scientific position peaked at $1.54B in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.